McKesson Beat Consensus Estimates

McKesson (MCK) reported earnings of $10.12 per share on revenue of $90.82 billion for the fiscal fourth quarter ended March 2025. The consensus earnings estimate was $9.81 per share on revenue of $93.70 billion. The company beat consensus estimates by 3.16% while revenue grew 18.95% on a year-over-year basis.

The company said it expects fiscal 2026 earnings of $36.75 to $37.55 per share. The current consensus earnings estimate is $36.58 per share for the year ending March 31, 2026.

McKesson Corporation distributes pharmaceuticals, medical supplies and healthcare information technology that make healthcare safer while reducing costs.